18 studies found for:    DatSCAN
Show Display Options
Rank Status Study
1 Completed Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Condition: Lewy Body Dementia
Intervention: Procedure: Single photon emission computed tomography and Magnetic Resonance Imaging
2 Enrolling by invitation DaTSCAN Imaging in Aging and Neurodegenerative Disease
Conditions: Dementia;   Parkinsonism;   Mild Cognitive Impairment
Interventions: Drug: DaTscan;   Device: Single photon emission computed tomography (SPECT) scan
3 Completed
Has Results
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Condition: Parkinsonian Syndromes
Intervention: Procedure: DaTSCAN SPECT imaging
4 Recruiting Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Interventions: Other: Imaging with IBVM;   Other: Imaging with DATSCAN;   Behavioral: neuropsychological evaluation
5 Recruiting Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM
6 Completed Dopaminergic Loss and Pain in Parkinson's Disease
Conditions: Parkinson's Disease;   Pain
Intervention: Drug: ioflupane 123I (DATSCAN®)
7 Completed Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Non-DLB Dementia;   Alzheimer’s;   Vascular Dementia
Intervention: Drug: DatSCAN
8 Enrolling by invitation Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
Conditions: Traumatic Brain Injury;   Parkinson's Disease
Intervention:
9 Completed Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Conditions: Parkinson Disease;   Parkinsonian Syndrome
Interventions: Drug: cabergoline;   Drug: carbidopa/levodopa;   Procedure: DATscan and SPECT imaging
10 Unknown  Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
Condition: Parkinson Disease
Intervention:
11 Unknown  Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics
Condition: Parkinson Disease
Intervention:
12 Recruiting Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Condition: Parkinson Disease
Intervention: Drug: Datscan and AV-133
13 Recruiting Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Conditions: Parkinson Disease;   Gaucher Disease;   Idiopathic Rapid Eye Movement Sleep Disorder
Intervention:
14 Unknown  Constitution of a Standardized Neural Imaging Database in Healthy Subjects
Condition: Healthy
Intervention: Procedure: SPET, PET and MRI
15 Recruiting Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects
Condition: Parkinson Disease
Interventions: Radiation: Group A - Early Imaging;   Radiation: Group B - Delayed Imaging
16 Recruiting Bee Venom for the Treatment of Parkinson Disease
Condition: Parkinson Disease
Intervention: Drug: bee venom
17 Active, not recruiting Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Transdermal nicotine;   Other: Usual drug treatment of Parkinson's disease
18 Recruiting Longitudinal, Single-center, Prospective Study to Obtain Detailed Clinical Information and Biologic Specimens From Patients With Parkinson's Disease (PD) Toward the Ultimate End of Identifying a Biomarker of PD.
Condition: Parkinson's Disease
Intervention:

Indicates status has not been verified in more than two years